Product Name

  • Name

    2,2'-Dibromodiethyl ether

  • EINECS 226-504-2
  • CAS No. 5414-19-7
  • Article Data30
  • CAS DataBase
  • Density 1.821 g/cm3
  • Solubility immiscible in water
  • Melting Point
  • Formula C4H8Br2O
  • Boiling Point 216.3 °C at 760 mmHg
  • Molecular Weight 231.915
  • Flash Point 85 °C
  • Transport Information
  • Appearance colourless liquid
  • Safety 53-26-36/37/39-45
  • Risk Codes 61-37/38-41
  • Molecular Structure Molecular Structure of 5414-19-7 (2,2'-Dibromodiethyl ether)
  • Hazard Symbols ToxicT,IrritantXi
  • Synonyms Ether,bis(2-bromoethyl) (6CI,7CI,8CI);1,1'-Oxybis[2-bromoethane];1,5-Dibromo-3-oxapentane;1-(2-Bromoethoxy)-2-bromoethane;1-Bromo-2-(2-bromoethoxy)ethane;2-(2-Bromoethoxy)ethyl bromide;2-Bromoethyl ether;3-Oxa-1,5-dibromopentane;Bis(2-bromoethyl) ether;Bis(b-bromoethyl) ether;Di(2-bromoethyl) ether;NSC 8025;b,b'-Dibromodiethyl ether;
  • PSA 9.23000
  • LogP 1.79280

Synthetic route

1,4-oxathiane-4,4-dioxide

1,4-oxathiane-4,4-dioxide

1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

Conditions
ConditionsYield
With hydrogen bromide at 20℃; for 12h; Temperature;82.1%
diethylene glycol
111-46-6

diethylene glycol

1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

Conditions
ConditionsYield
With phosphorus tribromide at 0 - 60℃; for 13h;80%
With phosphorus tribromide at 50 - 60℃; for 12h;80%
With phosphorus tribromide for 9.5h;33%
ethyl (2S)-2-[(diisopropylsilyl)oxy]propanoate
799296-23-4

ethyl (2S)-2-[(diisopropylsilyl)oxy]propanoate

2-bromoethanol
540-51-2

2-bromoethanol

A

1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

B

ethyl (2S)-2-{[(2-bromoethoxy)(diisopropyl)silyl]oxy}propanoate
1202570-30-6

ethyl (2S)-2-{[(2-bromoethoxy)(diisopropyl)silyl]oxy}propanoate

Conditions
ConditionsYield
With bromopentacarbonylmanganese(I) In dichloromethane at 20℃; for 2h;A n/a
B 68%
3-oxa-1,5-dichloropentane
111-44-4

3-oxa-1,5-dichloropentane

1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

Conditions
ConditionsYield
With potassium bromide In ethylene dibromide; N,N-dimethyl-formamide for 24h; Reflux;65%
diethylene glycol dimesylate
34604-52-9

diethylene glycol dimesylate

1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

Conditions
ConditionsYield
With lithium bromide In acetone for 20h; Heating / reflux;50%
With lithium bromide In acetone for 20h; Heating;
oxirane
75-21-8

oxirane

ethene
74-85-1

ethene

1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

Conditions
ConditionsYield
With bromine
With bromine In tetrachloromethane
1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

3,3′-(oxidi-2,1-ethanediyl)bis[1-methyl-imidazolium] dibromide

3,3′-(oxidi-2,1-ethanediyl)bis[1-methyl-imidazolium] dibromide

Conditions
ConditionsYield
In toluene Reflux; Inert atmosphere;100%
In toluene at 90℃; for 48h;99%
In acetonitrile for 48h; Reflux;95%
at 80℃; for 16h;
In 1,1,1-trichloroethane at 80℃; for 24h;
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

cis-(+/-)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one

cis-(+/-)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one

cis-2-[2-(2-bromoethoxy)ethyl]-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one

cis-2-[2-(2-bromoethoxy)ethyl]-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one

Conditions
ConditionsYield
Stage #1: cis-(+/-)-4-(3,4-dimethoxyphenyl)-4a,5,8,8a-tetrahydrophthalazin-1(2H)-one With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃;
Stage #2: 1,1'-oxybis(2-bromo-ethane) In N,N-dimethyl-formamide; mineral oil for 0.25h;
100%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

trans-4-(tert-butoxycarbonylamino)cyclohexylamine

trans-4-(tert-butoxycarbonylamino)cyclohexylamine

tert-butyl ((1,4-trans)-4-morpholinocyclohexyl)carbamate

tert-butyl ((1,4-trans)-4-morpholinocyclohexyl)carbamate

Conditions
ConditionsYield
With sodium carbonate In acetonitrile at 75℃; for 48h;100%
With triethylamine In N,N-dimethyl-formamide at 70℃; for 16h;
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

(3S)-4-[2-chloro-6-(methanesulfonylmethyl)pyrimidin-4-yl]-3-ethylmorpholine

(3S)-4-[2-chloro-6-(methanesulfonylmethyl)pyrimidin-4-yl]-3-ethylmorpholine

(3S)-4-[2-chloro-6-(4-methanesulfonyloxan-4-yl)pyrimidin-4-yl]-3-ethylmorpholine

(3S)-4-[2-chloro-6-(4-methanesulfonyloxan-4-yl)pyrimidin-4-yl]-3-ethylmorpholine

Conditions
ConditionsYield
With tetrabutylammomium bromide; sodium hydroxide In toluene at 90℃; for 2.25h; Sealed tube;100%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

borane-THF
14044-65-6

borane-THF

methylphenylphosphine
6372-48-1

methylphenylphosphine

2,2'-oxybis(ethane-2,1-diyl)bis(methylphenylphosphine-borane)
1147564-62-2, 1147564-78-0

2,2'-oxybis(ethane-2,1-diyl)bis(methylphenylphosphine-borane)

Conditions
ConditionsYield
With NaOCH(CH3)2CH2CH2; [RuH(1,2-bis(dimethylphosphino)ethane)((R)-DIFLUORPHOS)][tetraphenylborate] In tetrahydrofuran (N2); addn. of phosphine deriv. and benzyl chloride to THF soln. of sodium alcoholate deriv. and ruthenium compd., stirring at room temp. for 90min, addn. of THF soln. of borane deriv., stirring at room temp. for 30 min; addn. of water, extn. (ethyl acetate), washing with brine, drying over Na2SO4, filtration, concg., chromy. (silica gel, 75:25 hexanes/ethyl acetate), NMR and MS;99%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

trimethylamine
75-50-3

trimethylamine

(5-bromo-3-oxapentyl)trimethylammonium bromide

(5-bromo-3-oxapentyl)trimethylammonium bromide

Conditions
ConditionsYield
In tetrahydrofuran for 24h; Ambient temperature;98%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

diethyl malonate
105-53-3

diethyl malonate

(1-ethoxy-ethyl)-malonic acid diethyl ester
91368-89-7

(1-ethoxy-ethyl)-malonic acid diethyl ester

Conditions
ConditionsYield
With sodium In ethanol; hexane98%
With sodium In ethanol; hexane98%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

2-[3,5-bis(1-ethoxyethoxy)phenyl]acetonitrile

2-[3,5-bis(1-ethoxyethoxy)phenyl]acetonitrile

4-[3,5-bis(1-ethoxyethoxy)phenyl]tetrahydro-2H-pyran-4-carbonitrile

4-[3,5-bis(1-ethoxyethoxy)phenyl]tetrahydro-2H-pyran-4-carbonitrile

Conditions
ConditionsYield
Stage #1: 2-[3,5-bis(1-ethoxyethoxy)phenyl]acetonitrile With potassium hexamethylsilazane In tetrahydrofuran at -16℃; for 0.0833333h; Inert atmosphere;
Stage #2: 1,1'-oxybis(2-bromo-ethane) In tetrahydrofuran at -16℃; for 1h; Inert atmosphere;
98%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

1-(5-O-acetyl-2,3-dideoxy-β-D-glycero-pent-2-enofuranosyl)-thymine
77421-68-2

1-(5-O-acetyl-2,3-dideoxy-β-D-glycero-pent-2-enofuranosyl)-thymine

5'-O-acetyl-3-N-[2-(2-bromoethoxy)ethyl]-2',3'-didehydro-2',3'-dideoxythymidine
514213-69-5

5'-O-acetyl-3-N-[2-(2-bromoethoxy)ethyl]-2',3'-didehydro-2',3'-dideoxythymidine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 1.5h;97%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

1,5-diazido-3-oxapentane
24345-74-2

1,5-diazido-3-oxapentane

Conditions
ConditionsYield
With sodium azide In N,N-dimethyl-formamide at 60℃; for 10h;97%
With sodium azide In N,N-dimethyl-formamide at 60℃; Inert atmosphere;95%
With sodium azide In N,N-dimethyl-formamide at 55℃; for 3h;
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

2-(((1R,3R)-3-(benzyloxy)cyclohexyl)oxy)-5-bromopyridin-3-amine

2-(((1R,3R)-3-(benzyloxy)cyclohexyl)oxy)-5-bromopyridin-3-amine

4-(2-(((1R,3R)-3-(benzyloxy)cyclohexyl)oxy)-5-bromopyridin-3-yl)morpholine

4-(2-(((1R,3R)-3-(benzyloxy)cyclohexyl)oxy)-5-bromopyridin-3-yl)morpholine

Conditions
ConditionsYield
Stage #1: 2-(((1R,3R)-3-(benzyloxy)cyclohexyl)oxy)-5-bromopyridin-3-amine With sodium hydride In N,N-dimethyl-formamide; mineral oil at 25℃; for 0.5h;
Stage #2: 1,1'-oxybis(2-bromo-ethane) In N,N-dimethyl-formamide; mineral oil at 80℃; for 11.5h;
97%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

methyl salicylate
119-36-8

methyl salicylate

1,7-bis(2-(methoxycarbonyl)phenyl)-1,4,7-trioxaheptane
161724-78-3

1,7-bis(2-(methoxycarbonyl)phenyl)-1,4,7-trioxaheptane

Conditions
ConditionsYield
With potassium carbonate In acetone for 168h; Heating;96%
With potassium carbonate In acetone for 168h; Heating;90%
With potassium carbonate In acetone for 168h; Reflux;55%
With potassium carbonate In acetone Heating;
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

3-(2-imidazolin-1-yl)propyltriethoxysilane
63365-92-4

3-(2-imidazolin-1-yl)propyltriethoxysilane

3-[3-(triethoxysilyl)propyl]-1-[2-(2-{1-[3-(triethoxysilyl)propyl]-1H-imidazol-3-ium-3-yl}ethoxy)ethyl]-1H-imidazol-3-ium dibromide

3-[3-(triethoxysilyl)propyl]-1-[2-(2-{1-[3-(triethoxysilyl)propyl]-1H-imidazol-3-ium-3-yl}ethoxy)ethyl]-1H-imidazol-3-ium dibromide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 120℃; for 4h;96%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

4-chloro-7-fluoro-7-deazapurine
582313-57-3

4-chloro-7-fluoro-7-deazapurine

7-(2-[2-bromoethoxy]ethyl)-4-chloro-5-fluoro-7H-pyrrolo-[2,3-d]pyrimidine

7-(2-[2-bromoethoxy]ethyl)-4-chloro-5-fluoro-7H-pyrrolo-[2,3-d]pyrimidine

Conditions
ConditionsYield
Stage #1: 4-chloro-7-fluoro-7-deazapurine With sodium hydride In mineral oil at 0 - 22℃; for 0.166667h;
Stage #2: 1,1'-oxybis(2-bromo-ethane) In N,N-dimethyl-formamide; mineral oil at 60℃; for 2h;
96%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

6-hydroxy-2-chloroquinoline
577967-89-6

6-hydroxy-2-chloroquinoline

C22H18Cl2N2O3

C22H18Cl2N2O3

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 70℃; for 4h;95.8%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

ethyl (6-chloro-pyridin-3-yl)acetate
197376-47-9

ethyl (6-chloro-pyridin-3-yl)acetate

ethyl 4-(6-chloropyridin-3-yl)tetrahydro-2H-pyran-4-carboxylate

ethyl 4-(6-chloropyridin-3-yl)tetrahydro-2H-pyran-4-carboxylate

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran at -78 - 20℃; Inert atmosphere;95%
Stage #1: ethyl (6-chloro-pyridin-3-yl)acetate With sodium hydride In N,N-dimethyl-formamide; mineral oil for 0.666667h; Cooling with ice;
Stage #2: 1,1'-oxybis(2-bromo-ethane) In N,N-dimethyl-formamide; mineral oil at 0℃; for 3h;
0.82 g
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

2-(2-(difluoro(trifluoromethoxy)methoxy)-1,1,2,2-tetrafluoroethoxy)-N-(3-(dimethylamino)propyl)-2,3,3,3-tetrafluoropropanamide

2-(2-(difluoro(trifluoromethoxy)methoxy)-1,1,2,2-tetrafluoroethoxy)-N-(3-(dimethylamino)propyl)-2,3,3,3-tetrafluoropropanamide

N,N'-(oxybis(ethane-2,1-diyl))bis(1,1,1,3,3,5,5,6,6,8-decafluoro-N,N-dimethyl-9-oxo-8-(trifluoromethyl)-2,4,7-trioxa-10-azatridecan-13-aminium) bromide

N,N'-(oxybis(ethane-2,1-diyl))bis(1,1,1,3,3,5,5,6,6,8-decafluoro-N,N-dimethyl-9-oxo-8-(trifluoromethyl)-2,4,7-trioxa-10-azatridecan-13-aminium) bromide

Conditions
ConditionsYield
In acetonitrile at 80℃; for 12h; Schlenk technique;95%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

N,N',N'',N'''-tetratosyl-1,10-diamino-4,7-diazadecane
74676-47-4

N,N',N'',N'''-tetratosyl-1,10-diamino-4,7-diazadecane

4,8,11,15-tetrakis(p-tolylsulphonyl)-1-oxa-4,8,11,15-tetraazacycloheptadecane
120808-61-9

4,8,11,15-tetrakis(p-tolylsulphonyl)-1-oxa-4,8,11,15-tetraazacycloheptadecane

Conditions
ConditionsYield
With sodium hydroxide; tetra-(n-butyl)ammonium iodide In toluene for 10h; Heating;94%
With sodium hydroxide; tetra-(n-butyl)ammonium iodide In water; toluene for 9h; Heating;94%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

(1S,2S,3R,5S)-3-amino-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol
69363-09-3

(1S,2S,3R,5S)-3-amino-2,6,6-trimethylbicyclo[3.1.1]heptan-2-ol

(1S,2S,3R,5S)-2,6,6-trimethyl-3-morpholinobicyclo[3.1.1]heptan-2-ol

(1S,2S,3R,5S)-2,6,6-trimethyl-3-morpholinobicyclo[3.1.1]heptan-2-ol

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 18h; Reflux;94%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

2-bromo-5-((4-(3-hydroxyphenyl)pyrimidin-2-yl)amino)phenol

2-bromo-5-((4-(3-hydroxyphenyl)pyrimidin-2-yl)amino)phenol

C20H18BrN3O3

C20H18BrN3O3

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 75℃; for 20h;94%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

diethylene glycol dinitrate
693-21-0

diethylene glycol dinitrate

Conditions
ConditionsYield
With silver nitrate In acetonitrile at 70℃; for 16h; Darkness;93.4%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

(1S,2R)-(+)-norphedrine
37577-28-9

(1S,2R)-(+)-norphedrine

(1S,2R)-2-(morpholin-4-yl)-1-phenylpropanol

(1S,2R)-2-(morpholin-4-yl)-1-phenylpropanol

Conditions
ConditionsYield
With sodium hydrogencarbonate In toluene for 22.5h; Heating;93%
Stage #1: 1,1'-oxybis(2-bromo-ethane); (1S,2R)-(+)-norphedrine With sodium hydrogencarbonate In toluene at 115℃; for 22.5h;
Stage #2: With sodium hydroxide In water pH=13;
93%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

1-(6-chloropyridin-3-yl)cyclohexanamine

1-(6-chloropyridin-3-yl)cyclohexanamine

4-(1-(6-chloropyridin-3-yl)cyclohexyl)morpholine

4-(1-(6-chloropyridin-3-yl)cyclohexyl)morpholine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 120℃; Sealed tube;93%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

(3-bromophenyl)acetonitrile
31938-07-5

(3-bromophenyl)acetonitrile

4-(3-Bromo-phenyl)-tetrahydro-pyran-4-carbonitrile
245439-36-5

4-(3-Bromo-phenyl)-tetrahydro-pyran-4-carbonitrile

Conditions
ConditionsYield
Stage #1: (3-bromophenyl)acetonitrile With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.25h;
Stage #2: 1,1'-oxybis(2-bromo-ethane) In N,N-dimethyl-formamide at 0 - 20℃; for 4h;
93%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

7-Hydroxy-3-(4-methoxy-phenyl)-chromen-4-on
485-72-3

7-Hydroxy-3-(4-methoxy-phenyl)-chromen-4-on

7-(2-(2-bromoethoxy)-ethoxy)-3-(4-methoxyphenyl)-4H-chromen-4-one

7-(2-(2-bromoethoxy)-ethoxy)-3-(4-methoxyphenyl)-4H-chromen-4-one

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃; for 10h;93%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

3'-azido-2',3'-deoxythymidine
30516-87-1

3'-azido-2',3'-deoxythymidine

3'-azido-3-N-(5-bromoethyl ether)-3'-deoxythymidine

3'-azido-3-N-(5-bromoethyl ether)-3'-deoxythymidine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; acetone for 24h; Alkylation; Heating;92%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

4,4'-bis(hydroxy)-3,3'-oxybis(ethyleneoxy)dibenzaldehyde
486395-57-7

4,4'-bis(hydroxy)-3,3'-oxybis(ethyleneoxy)dibenzaldehyde

6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2,14-dicarbaldehyde
90265-03-5

6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2,14-dicarbaldehyde

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 80℃; for 43.5h; Williamson macrocyclization;92%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

p-aminophenylacetonitrile
3544-25-0

p-aminophenylacetonitrile

2-[4-(morpholin-4-yl)phenyl]acetonitrile
1000512-72-0

2-[4-(morpholin-4-yl)phenyl]acetonitrile

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In toluene for 20h; Reflux;92%
With N-ethyl-N,N-diisopropylamine In toluene for 20h; Reflux;92%
With N-ethyl-N,N-diisopropylamine In toluene for 20h; Reflux;
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(R)-2-morpholino-2-phenylethan-1-ol

(R)-2-morpholino-2-phenylethan-1-ol

Conditions
ConditionsYield
With potassium carbonate In ethanol at 80℃; for 24h;92%
1,1'-oxybis(2-bromo-ethane)
5414-19-7

1,1'-oxybis(2-bromo-ethane)

tert-butyl {[5-(4-butoxyphenyl)thien-2-yl]sulfonyl}acetate
701270-40-8

tert-butyl {[5-(4-butoxyphenyl)thien-2-yl]sulfonyl}acetate

tert-butyl 4-{[5-(4-butoxyphenyl)thien-2-yl]sulfonyl}tetrahydro-2H-pyran-4-carboxylate
701270-41-9

tert-butyl 4-{[5-(4-butoxyphenyl)thien-2-yl]sulfonyl}tetrahydro-2H-pyran-4-carboxylate

Conditions
ConditionsYield
With 18-crown-6 ether; potassium carbonate In DMF (N,N-dimethyl-formamide) at 65℃; for 15h;91%

2,2'-Dibromodiethyl ether Specification

The Ethane,1,1'-oxybis[2-bromo-, with the cas registry number 5414-19-7, has the IUPAC name of 1-bromo-2-(2-bromoethoxy)ethane. Being a kind of colourless liquid, it is combustible and incompatible with oxidizing agents, acid chlorides, chloroformates, reducing agents, halogens. And its product categories are various, including Aliphatics; Halides; Ethers; Organic Building Blocks; Oxygen Compounds.

The characteristics of this chemical are as follows: (1)ACD/LogP: 1.87; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.87; (4)ACD/LogD (pH 7.4): 1.87; (5)ACD/BCF (pH 5.5): 15.64; (6)ACD/BCF (pH 7.4): 15.64; (7)ACD/KOC (pH 5.5): 249.2; (8)ACD/KOC (pH 7.4): 249.2; (9)#H bond acceptors: 1; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 9.23; (13)Index of Refraction: 1.505; (14)Molar Refractivity: 37.78 cm3; (15)Molar Volume: 127.2 cm3; (16)Polarizability: 14.98 ×10-24 cm3; (17)Surface Tension: 37.6 dyne/cm; (18)Density: 1.821 g/cm3; (19)Flash Point: 85 °C; (20)Enthalpy of Vaporization: 43.42 kJ/mol; (21)Boiling Point: 216.3 °C at 760 mmHg; (22)Vapour Pressure: 0.207 mmHg at 25°C; (23)Exact Mass: 231.892143; (24)MonoIsotopic Mass: 229.89419; (25)Topological Polar Surface Area: 9.2; (26)Heavy Atom Count: 7; (27)Formal Charge: 0; (28)Complexity: 28.9.

When you are dealing with this chemical, you should be much more careful. For being a kind of irritant chemical to respiratory system and skin, it may cause inflammation to the skin or other mucous membranes. If inadequately used, it may have risk of serious damage to eyes and may cause harm to the unborn child. Then it is toxic which may at low levels cause damage to health. Therefore, you should take the following instructions to protect yourself. Wear suitable protective clothing, gloves and eye/face protection. If in case of contact with eyes, rinse immediately with plenty of water and seek medical advice, and if in case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Then remember to avoid exposure - obtain special instructions before use.

Additionally, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: C(CBr)OCCBr
(2)InChI: InChI=1S/C4H8Br2O/c5-1-3-7-4-2-6/h1-4H2
(3)InChIKey: FOZVXADQAHVUSV-UHFFFAOYSA-N 

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View